5Pickup J,Williams G. Textbook of diabetes[A].Oxford UK:Blackwell of Science Ltd,1997.56.
6Guidel Ines Subcommittee. 1999 World or ganization-international society of hypertension guidelines for the management of hypertension[J].Journal of Hypertension,1999.15.
7ADA. Position statement:Implications of the united kingdom prospective diabetes study[J].Diabetes Care,1999,(Suppl 1):S27.
8Brohall G,Oden A,Fagerberg B. Carotid artery intima madia thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance:a systematic review[J].Diabetic Medicine,2006,(06):609-616.
9Fujita M,Asanuma H,Kim J. Impaired glucose tolerance:a possible contributor to left ventricular hypertrophy and diastolic dysfunction[J].International Journal of Cardiology,2007,(01):76-80.
1[1]ARANG P C,RASKIN P. Hypertention in diabetes mellitus[J]. Endocrinol Metab Clin North Am, 1996, 25: 401
2[2]THE HYPERTENTION IN DIABETES STUDY GROUP. Hypertention in diabetes study (HDS) II: Increased risk of cardiovascular complications in hypertensive type 2 diabetes[J]. J Hypertens, 1993, 11: 319
3[3]REAVEN G M, LITHELL H, LANDSBERG L. Mechanism of disease: Hypertention and associated metabolic abnormalities-the role of insulin resistance and the sympathoadnenal system[J]. N Engl J Med, 1996, 334(6): 374
4[4]PICKUP J , WILLIAMS G. Textbook of diabetes. In: Nilsson PM. Hypertention and diabetes mellitus[J]. Blackwell of Science Ltd, 1997, 56: 1
5[5]MOGENSEN C E. Combined high blood pressure and glucose in type 2 diabetes: double jeopardy[J]. B M J, 1998, 317: 693
6[6]GUIDELINES SUBCOMMITTEE. 1999 World organization-international society of hypertension guidelines for the management of hypertension[J]. J Hypertens, 1999, 17: 15
7[7]PAHOR M, PASTY B M, FURBERG C D. Treatment of hypertensive patients with diabetes[J]. Lancet, 1998, 351: 689
8[8]MESSERLI F H, GROSSMAN E, MICHALEWICZ L. Combination therapy and target organ protection in hypertension and diabetes mellitus[J]. Am J Hypertens, 1997, 10: 198
9[9]HANSSON L, ZANCHETTI A, GARRUTHERS S G, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial[J]. Lancet, 1998, 351: 1755
10[10]UKPDS GROUP. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes[J]. UKPDS 39. B M J, 1998, 317: 713
4Candrilli SD, Davis KL, Kan HJ, et al. Prevalence and the associat-ed burden of illness of symptoms of diabetic peripheral neuropathyand diabetic retinopathy [ J ]. J Diabetes Complications, 2007,21(5):306 -314.
5Abe M,0kada K,Maruyama T,et al. Combination therapy with m-itiglinide and voglibose improves glycemic control in type 2 diabeticpatients on hemodialysis [ J ] . Expert Opin Pharmacother, 2010 , 11(2):169 -76.
6Fujitaka K, Otani H , Jo F, et al. Comparison of metabolic profileand adiponectin level with pioglitazone versus voglibose in patientswith type - 2 diabetes mellitus associated with metabolic syndrome[J]. Endocr J,2011,58(6) :425 -432.
8Fujitaka K,Otani H,Jo F,et al.Comparison of metabolic profileand adiponectin level with pioglitazone versus voglibose in patientswith type-2 diabetes mellitus associated with metabolic syndrome[J].Endocr J,2011,58(6):425-432.
9Candrilli SD,Davis KL,Kan HJ,et al.prevalence and the associat-ed burden of illness of symptoms of diabetic peripheral neuropathyand diabetic retinopathy[J].J Diabetes Complications,2007,21(5):306-314.
